Artiva Biotherapeutics, Inc.
HealthcareNASDAQ:ARTV · NASDAQ Global Market
+$0.54 today
Vol 1.43M · Avg 0.45M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+331.31%
Period High
$13.39
Period Low
$1.47
Latest
$8.54
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Sutro Biopharma, Inc.
NASDAQ:STRO
$278.70M
Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTL
$266.95M
Shattuck Labs, Inc.
NASDAQ:STTK
$236.64M
ALX Oncology Holdings Inc.
NASDAQ:ALXO
$212.61M
Connect Biopharma Holdings Limited
NASDAQ:CNTB
$133.48M
InflaRx N.V.
NASDAQ:IFRX
$115.57M
Adverum Biotechnologies, Inc.
ADVM
$96.26M
Precision BioSciences, Inc.
NASDAQ:DTIL
$78.25M
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
$61.36M
Metagenomi, Inc. Common Stock
MGX
$45.18M
What is the latest ARTV filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does ARTV have?
Intrinsic Alpha currently shows 20 recent filings for ARTV.
Explore More
Continue the stock analysis
Jump to another research area for this company.